Peking Union Medical College Hospital clinical trial pipeline

23 trials changed in the last 30 days: 3 stopped, 11 with notable changes, 9 with minor changes only.

1. Stopped

   Cohort Study on the Safety and Efficacy of XH-02 in Treating…Cohort Study on the Safety and Efficacy of XH-02 in Treating Hypoparathyroidism

   Recruitment suspended

   Peking Union Medical College Hospital·Phase 2· NCT07540286· Registry history of NCT07540286 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

2. Stopped

   Subcutaneous Injection of XH-02 · Adult Hypoparathyroidism

   Recruitment suspended

   Also in this update: Primary completion pushed from May 31, 2026 to May 30, 2027; Study completion pushed from Jun 30, 2026 to Aug 30, 2027

   Peking Union Medical College Hospital·Phase 1/2· NCT07530705· Registry history of NCT07530705 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

3. Stopped

   XH02 · XH02 · Hypoparathyroidism

   Recruitment suspended

   Also in this update: Primary completion pushed from Jul 15, 2026 to May 30, 2027; Study completion pushed from Jul 30, 2026 to Aug 30, 2027

   Peking Union Medical College Hospital·Early Phase 1· NCT07197450· Registry history of NCT07197450 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

4. Notable

   PILOT-BTC · Polymeric Micellar Paclitaxel-Based Combination…PILOT-BTC · Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer

   Primary completion pushed from Aug 12, 2026 to Aug 7, 2027

   Also in this update: Enrollment reduced: 61 → 25 participants; Enrollment reopened

   Peking Union Medical College Hospital·Phase 2· NCT07159204· Registry history of NCT07159204 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

5. Notable

   POASAC Study (Preoperative Anemia Severity and Classification…POASAC Study (Preoperative Anemia Severity and Classification Study)

   Primary completion pushed from Dec 31, 2026 to Dec 31, 2027

   Also in this update: Study completion pushed from Dec 31, 2027 to Dec 31, 2028

   Peking Union Medical College Hospital·Not specified· NCT06499974· Registry history of NCT06499974 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

6. Notable

   Faecal Microbiota Transplantation · Refractory Rheumatoid Arthritis

   Primary completion pushed from Jun 1, 2028 to Jun 30, 2031

   Also in this update: Recruitment opened; Study completion pushed from Dec 31, 2028 to Dec 31, 2031

   Peking Union Medical College Hospital·Phase 2· NCT07639177· Registry history of NCT07639177 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

7. Notable

   Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA)…Single-center, Open-label Study of Inhaled BMD003 (CFTR mRNA) · Cystic Fibrosis

   Primary completion pushed from May 10, 2026 to Dec 13, 2026

   Also in this update: Trial status changed: Not Yet Recruiting → Active, Not Recruiting

   Peking Union Medical College Hospital·Early Phase 1· NCT06963008· Registry history of NCT06963008 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

8. Notable

   Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging…Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

   Primary and study completion pushed from Dec 1, 2025 to Dec 31, 2027

   Peking Union Medical College Hospital·Early Phase 1· NCT06411678· Registry history of NCT06411678 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

9. Notable

   BAO-G-02 · BAO-G Technique in Complex Aortic Aneurysm…BAO-G-02 · BAO-G Technique in Complex Aortic Aneurysm Endovascular Repair (BAO-G-02)

   Phase changed: Phase 1 → not applicable

   Peking Union Medical College Hospital·Not applicable· NCT07141251· Registry history of NCT07141251 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

10. Notable

    Tegileridine for Postoperative Pain After Adolescent Scoliosis…Tegileridine for Postoperative Pain After Adolescent Scoliosis Surgery

    Recruitment opened

    Also in this update: Primary completion pushed from Jun 30, 2027 to Oct 30, 2027; Study completion pushed from Sep 30, 2027 to Dec 30, 2027

    Peking Union Medical College Hospital·Phase 4· NCT07229495· Registry history of NCT07229495 on ClinicalTrials.gov (opens the registry)

    Oct 13, 2026

11. Notable

    AI-assisted Rare Disease Diagnosis

    Recruitment opened

    Peking Union Medical College Hospital·Not applicable· NCT07650799· Registry history of NCT07650799 on ClinicalTrials.gov (opens the registry)

    Oct 13, 2026

12. Notable

    SIB-NCRT · Simultaneous Boost in Neoadjuvant Radiotherapy for…SIB-NCRT · Simultaneous Boost in Neoadjuvant Radiotherapy for Rectal Cancer

    Recruitment opened

    Peking Union Medical College Hospital·Phase 2· NCT07200141· Registry history of NCT07200141 on ClinicalTrials.gov (opens the registry)

    Sep 21, 2026

13. Notable

    Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients…Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years

    Recruitment opened

    Peking Union Medical College Hospital·Early Phase 1· NCT07485543· Registry history of NCT07485543 on ClinicalTrials.gov (opens the registry)

    Oct 1, 2026

14. Notable

    Impact of LBBAP vs RVP on the Incidence of New-onset Atrial…Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation · Atrioventricular Block

    Recruitment opened

    Peking Union Medical College Hospital·Not applicable· NCT06023784· Registry history of NCT06023784 on ClinicalTrials.gov (opens the registry)

    Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.